首页 > 最新文献

中国综合临床最新文献

英文 中文
Study on the relationship between vitamin D, grip strength and muscle mass in elderly diabetic patients 老年糖尿病患者维生素D、握力与肌肉质量关系的研究
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.013
Z. Mu, S. Xiu, Li Wang
Objective To study the relationship between vitamin D level and muscle mass and grip strength in elderly patients with type 2 diabetes mellitus (T2DM). Methods From May 2016 to January 2018, 201 patients with type 2 diabetes mellitus aged ≥ 60 who were admitted to the Department of endocrinology of Xuanwu Hospital were selected for prospective study. According to 25-hydroxyvitamin D level(25(OH)D), the patients were divided into the vitamin D deficiency group (25(OH)D<20 μg/L, 140 cases) and the non-deficiency group (20 μg/L≤25(OH)D<70 μg/L, 61 cases). The grip strength, walking speed and muscle mass of upper and lower limbs were measured.Physical examination and laboratory examination were carried out. Results There was no significant difference between the two groups (P>0.05). The grip strength, upper limb and lower limb muscle contents in the non deficiency group were significantly higher than those in the deficiency group ((33.49±9.43) kg vs.(29.59±10.30) kg, (4.99±1.09) kg vs.(4.57±1.11) kg, (15.69±3.10) kg vs.(14.54±3.03) kg, P=0.01, 0.015, 0.017). Multivariate logistic regression analysis showed that vitamin D deficiency was independently related to grip strength and lower limb muscle mass(OR=1.286, 95% CI: 1.197-1.346, P<0.01; OR=1.231, 95%CI: 1.102-1.283, P<0.05). Conclusion Vitamin D deficiency is a risk factor for the decrease of grip strength and lower extremity muscle mass in elderly patients with type 2 diabetes. Key words: Type 2 diabetes; Vitamin D; Grip; Muscle mass
目的探讨老年2型糖尿病(T2DM)患者维生素D水平与肌肉质量和握力的关系。方法选择2016年5月至2018年1月入住宣武医院内分泌科的201例年龄≥60岁的2型糖尿病患者进行前瞻性研究。根据25-羟基维生素D水平(25(OH)D),将患者分为维生素D缺乏组(25(OHD0.05)。非缺乏组的握力、上肢和下肢肌肉含量显著高于缺乏组((33.49±9.43)kg对(29.59±10.30)kg、(4.99±1.09)kg对,0.015,结论维生素D缺乏是老年2型糖尿病患者握力和下肢肌肉质量下降的危险因素。关键词:2型糖尿病;维生素D;握力;肌肉质量
{"title":"Study on the relationship between vitamin D, grip strength and muscle mass in elderly diabetic patients","authors":"Z. Mu, S. Xiu, Li Wang","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.013","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.013","url":null,"abstract":"Objective \u0000To study the relationship between vitamin D level and muscle mass and grip strength in elderly patients with type 2 diabetes mellitus (T2DM). \u0000 \u0000 \u0000Methods \u0000From May 2016 to January 2018, 201 patients with type 2 diabetes mellitus aged ≥ 60 who were admitted to the Department of endocrinology of Xuanwu Hospital were selected for prospective study. According to 25-hydroxyvitamin D level(25(OH)D), the patients were divided into the vitamin D deficiency group (25(OH)D<20 μg/L, 140 cases) and the non-deficiency group (20 μg/L≤25(OH)D<70 μg/L, 61 cases). The grip strength, walking speed and muscle mass of upper and lower limbs were measured.Physical examination and laboratory examination were carried out. \u0000 \u0000 \u0000Results \u0000There was no significant difference between the two groups (P>0.05). The grip strength, upper limb and lower limb muscle contents in the non deficiency group were significantly higher than those in the deficiency group ((33.49±9.43) kg vs.(29.59±10.30) kg, (4.99±1.09) kg vs.(4.57±1.11) kg, (15.69±3.10) kg vs.(14.54±3.03) kg, P=0.01, 0.015, 0.017). Multivariate logistic regression analysis showed that vitamin D deficiency was independently related to grip strength and lower limb muscle mass(OR=1.286, 95% CI: 1.197-1.346, P<0.01; OR=1.231, 95%CI: 1.102-1.283, P<0.05). \u0000 \u0000 \u0000Conclusion \u0000Vitamin D deficiency is a risk factor for the decrease of grip strength and lower extremity muscle mass in elderly patients with type 2 diabetes. \u0000 \u0000 \u0000Key words: \u0000Type 2 diabetes; Vitamin D; Grip; Muscle mass","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49623725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the relationship between Plasma Pro amino terminal brain natriuretic peptide, left ventricular mass index and the prognosis in elderly heart failure patients with preserved ejection fraction 保留射血分数的老年心力衰竭患者血浆氨基末端前脑利钠肽、左心室质量指数与预后关系的研究
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.011
Lei Zhou
Objective To investigate the clinical value of plasma N-terminal pro-brain natriuretic peptide(NT-proBNP)and Left ventricular mass index(LVMI )in evaluating the prognosis of elderly heart failure patients with preserved ejection fraction (HFpEF). Methods From January 2018 to December 2018, 170 patients with heart failure (age≥65years old) in the Third Affiliated Hospital of Anhui Medical University were selected as the subjects of prospective study.According to the left ventricular ejection fraction (LVEF), the patients were divided into two groups: the heart failure with preserved ejection fraction (HFpEF) group (100 cases), the heart failure with reduced ejection fraction (HFrEF) group (70 cases), and the healthy subjects (58 cases) as the control group.Left atrial diameter (LAD), interventricular septum thickness (IVST), left ventricular posterior wall thickness (LVPWT), left ventricular end diastolic diameter (LVEDD), LVEF, left ventricular mass index (LVMI) and plasma NT-proBNP concentrations were compared among the three groups.The study group was followed up for 6 months after standardized treatment to observe the occurrence of major cardiovascular adverse events (MACE). Multiple logistic regression was used to analyze the correlation between the above indexes and the occurrence of mace.ROC curve was used to analyze the predictive value of NT proBNP and LVMI. Results There were significant differences in LAD, IVSTt, LVPWT, LVEDD, LVEF and LVMI among each group (F value was 110.878, 75.838, 74.044, 137.985, 495.267 and 122.810, respectively, all P<0.001 ). The LAD, IVST, LVPWT, LVEDD, and LVMI in the HFpEF group((40.81 ±4.46) mm, (9.39±1.15) mm, (9.68±1.11) mm, (55.54±3.67) mm, (125.45±19.17) g/m2) were higher than those in the control group ((32.9±3.20) mm, (7.62±0.64) mm, (7.81±0.58) mm, (47.05±3.13) mm, (77.72±11.79) g/m2), and the LVEF was lower than that of the control group ((59.63±5.23)% vs.(67.7±4.35)%) with statistical significance (all P<0.05). IVST, LVPWT, LVEF in HFpEF group( (9.39±1.15) mm, (9.68±1.11) mm, (9.63±5.23)%) were higher than those in HFrEF group ((7.59±1.28) mm, (8.01±1.39) mm, (36.9±7.63 )%) ; and the LAD, LVEDD in HFpEF group ((40.81±4.46) mm, (55.54±3.67) mm) were lower than those in HFrEF group ((45.51±6.1) mm, (64.77±9.55) mm), and the differences were statistically significant (all P<0.05). The plasma NT-proBNP concentration was the lowest in the control group, followed by the HFpEF group and the highest in the HFrEF group(56.0 (30.0, 78.56), 2 624.5 (1 190.5, 5 558.5), 8 528.5 (2 651.0, 21 582.75), F=81.355, P<0.01). Multivariant Logistic regression analysis showed that NT-proBNP and LVMI were independent risk factors for occurrence of MACE in patients with HFpEF(OR=4.796, 95%CI: 2.348-5.127, P=0.035; OR=1.957, 95%CI: 1.810-3.327, P=0.016). ROC curve analysis showed that the area under the curve of cardiovascular adverse events predicted by NT-proBNP and LVMI for 6 months was 0.888(95%CI: 0.825-0
目的探讨血浆N-末端脑钠素原(NT-proBNP)和左心室质量指数(LVMI)在评价射血分数保留的老年心力衰竭患者预后中的临床价值。方法选择安徽医科大学附属第三医院2018年1月至2018年12月收治的170例年龄≥65岁的心力衰竭患者作为前瞻性研究对象。根据左心室射血分数(LVEF),将患者分为两组:保留射血分数心力衰竭(HFpEF)组(100例)、降低射血分数心衰组(HFrEF)(70例)和健康受试者(58例)作为对照组。比较三组患者的左心房直径(LAD)、室间隔厚度(IVST)、左心室后壁厚度(LVPWT)、左室舒张末期直径(LVEDD)、LVEF、左心室质量指数(LVMI)和血浆NT-proBNP浓度。研究组在标准化治疗后随访6个月,观察主要心血管不良事件(MACE)的发生情况。采用多元逻辑回归分析上述指标与狼牙病发生的相关性。ROC曲线用于分析NT-proBNP和LVMI的预测价值。结果各组LAD、IVSTt、LVPWT、LVEDD、LVEF和LVMI均有显著性差异(F值分别为110.878、75.838、74.044、137.985、495.267和122.810,P均<0.001)。HFpEF组的LAD、IVST、LVPWT、LVEDD和LVMI((40.81±4.46)mm、(9.39±1.15)mm、,LVEF低于对照组(59.63±5.23)%与(67.7±4.35)%,差异有统计学意义(均P<0.05),HFpEF组IVST、LVPWT、LVEF分别为(9.39±1.15)mm、(9.68±1.11)mm和(9.63±5.23;HFpEF组的LAD、LVEDD((40.81±4.46)mm,(55.54±3.67)mm)均低于HFrEF组的(45.51±6.1)mm、(64.77±9.55)mm,差异有统计学意义(均P<0.05),8 528.5(2 651.0,21 582.75),F=81.355,多元Logistic回归分析显示,NT-proBNP和LVMI是HFpEF患者发生MACE的独立危险因素(OR=4.796,95%CI:2.348-5.127,P=0.035;OR=1.957,95%CI:1.810-3.327,P=0.016)结论NT-proBNP和LVMI对老年HFpEF患者的预后评估具有重要价值。关键词:心力衰竭;射血分数保留的心力衰竭;N-末端脑钠肽原;左心室质量指数;预后
{"title":"Study on the relationship between Plasma Pro amino terminal brain natriuretic peptide, left ventricular mass index and the prognosis in elderly heart failure patients with preserved ejection fraction","authors":"Lei Zhou","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.011","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.011","url":null,"abstract":"Objective \u0000To investigate the clinical value of plasma N-terminal pro-brain natriuretic peptide(NT-proBNP)and Left ventricular mass index(LVMI )in evaluating the prognosis of elderly heart failure patients with preserved ejection fraction (HFpEF). \u0000 \u0000 \u0000Methods \u0000From January 2018 to December 2018, 170 patients with heart failure (age≥65years old) in the Third Affiliated Hospital of Anhui Medical University were selected as the subjects of prospective study.According to the left ventricular ejection fraction (LVEF), the patients were divided into two groups: the heart failure with preserved ejection fraction (HFpEF) group (100 cases), the heart failure with reduced ejection fraction (HFrEF) group (70 cases), and the healthy subjects (58 cases) as the control group.Left atrial diameter (LAD), interventricular septum thickness (IVST), left ventricular posterior wall thickness (LVPWT), left ventricular end diastolic diameter (LVEDD), LVEF, left ventricular mass index (LVMI) and plasma NT-proBNP concentrations were compared among the three groups.The study group was followed up for 6 months after standardized treatment to observe the occurrence of major cardiovascular adverse events (MACE). Multiple logistic regression was used to analyze the correlation between the above indexes and the occurrence of mace.ROC curve was used to analyze the predictive value of NT proBNP and LVMI. \u0000 \u0000 \u0000Results \u0000There were significant differences in LAD, IVSTt, LVPWT, LVEDD, LVEF and LVMI among each group (F value was 110.878, 75.838, 74.044, 137.985, 495.267 and 122.810, respectively, all P<0.001 ). The LAD, IVST, LVPWT, LVEDD, and LVMI in the HFpEF group((40.81 ±4.46) mm, (9.39±1.15) mm, (9.68±1.11) mm, (55.54±3.67) mm, (125.45±19.17) g/m2) were higher than those in the control group ((32.9±3.20) mm, (7.62±0.64) mm, (7.81±0.58) mm, (47.05±3.13) mm, (77.72±11.79) g/m2), and the LVEF was lower than that of the control group ((59.63±5.23)% vs.(67.7±4.35)%) with statistical significance (all P<0.05). IVST, LVPWT, LVEF in HFpEF group( (9.39±1.15) mm, (9.68±1.11) mm, (9.63±5.23)%) were higher than those in HFrEF group ((7.59±1.28) mm, (8.01±1.39) mm, (36.9±7.63 )%) ; and the LAD, LVEDD in HFpEF group ((40.81±4.46) mm, (55.54±3.67) mm) were lower than those in HFrEF group ((45.51±6.1) mm, (64.77±9.55) mm), and the differences were statistically significant (all P<0.05). The plasma NT-proBNP concentration was the lowest in the control group, followed by the HFpEF group and the highest in the HFrEF group(56.0 (30.0, 78.56), 2 624.5 (1 190.5, 5 558.5), 8 528.5 (2 651.0, 21 582.75), F=81.355, P<0.01). Multivariant Logistic regression analysis showed that NT-proBNP and LVMI were independent risk factors for occurrence of MACE in patients with HFpEF(OR=4.796, 95%CI: 2.348-5.127, P=0.035; OR=1.957, 95%CI: 1.810-3.327, P=0.016). ROC curve analysis showed that the area under the curve of cardiovascular adverse events predicted by NT-proBNP and LVMI for 6 months was 0.888(95%CI: 0.825-0","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42438795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of the factors influencing the pathological complete remission and prognosis of young breast cancer patients after neoadjuvant chemotherapy 影响年轻乳腺癌患者新辅助化疗后病理完全缓解及预后的因素分析
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.002
Weina Chen, Yantao Wang, W. Di, B. Kong
Objective To explore the clinicopathological factors that influence the prognosis and pathological complete response (PCR) of young breast cancer patients after neoadjuvant chemotherapy. Methods From January 2007 to December 2017, 87 cases of female breast cancer patients aged ≤40 who received neoadjuvant chemotherapy and were admitted to the breast surgery department of Qingdao 8th people′s hospital were analyzed retrospectively.According to the pathological results, , the patients were divided into three groups: 30 in the PCR group and 57 in the non PCR group. To compare the correlation between the composition of PCR, recurrence/metastasis and death and clinicopathological characteristics, and to analyze the relationship between PCR and disease-free survival(DFS) and overall survival(OS). Results After neoadjuvant chemotherapy, 30 of the 87 patients reached to PCR (34.5%). The proportion of PCR after neoadjuvant chemotherapy in young breast cancer is related to estrogen receptor (ER), progesterone receptor (PR), preoperative lymph node status, Ki67 level and molecular typing( χ2 values were 3.592, 4.614, 8.373, 4.251 and 14.569, respectively, P values were 0.047, 0.032, 0.039, 0.039 and 0.006, respectively; the proportion of recurrence and metastasis patients with Er, PR and human epidermal growth factor receptor 2 2, HER-2, tumor size and lymph node status were correlated (χ2 values were 8.778, 6.243, 9.413, 14.910, 23.074, P values were 0.003, 0.013, 0.009, 0.002, < 0.001, respectively); the proportion of dead patients was correlated with Er, PR, HER-2, grade, tumor size and lymph node status (χ2 values were 6.686, 4.340, 11.874, 15.707, 12.428, 26.564, respectively, P values were 0.010, 0.037, 0.003, < 0.001, 0.006, < 0.001). Er, PR, HER-2, tumor size, preoperative lymph node status and molecular typing were correlated with DFS (HR(95%CI) was 0.53 (0.31-0.93), 2.12 (1.21-3.64), 0.46 (0.27-0.77), 1.91 (1.40-2.62), 2.22 (1.55-3.20), 1.21 (0.95-1.55), all P< 0.05), while er, PR, HER-2, classification, tumor size and preoperative lymph node status were closely correlated with OS (HR(95%CI was 0.47 (0.23-0.98), 2.14 (1.03-4.44), 0.37 (0.19-0.76), 2.90 (1.45-5.79), 1.86 (1.24-2.79) and 2.22 (1.39-3.56), respectively (all P < 0.05)). Among the 33 patients with recurrence and metastasis, 5 (16.7%)patients had PCR, while the remaining 28 (49.1%)patients had not reached PCR, accounting for 49.1% (28/57) of all the non PCR patients. The difference between the two groups was statistically significant (P = 0.019). Among the 21 patients who died, there were 2 patients with PCR, accounting for 6.7% (2/30) of all the patients with PCR; the remaining 19 patients did not reach PCR, accounting for 33.3% (19/57) of all the patients without PCR. The difference between the two groups was statistically significant(P= 0.026). Conclusion The proportion of PCR, DFS and OS in young breast cancer patients after neoadjuvant chemotherapy were affected
目的探讨影响年轻乳腺癌患者新辅助化疗后预后及病理完全缓解(PCR)的临床病理因素。方法回顾性分析2007年1月至2017年12月青岛市第八人民医院乳腺外科收治的87例年龄≤40岁接受新辅助化疗的女性乳腺癌患者。根据病理结果将患者分为三组:PCR组30例,非PCR组57例。比较PCR组成、复发/转移及死亡与临床病理特征的相关性,分析PCR与无病生存期(DFS)和总生存期(OS)的关系。结果87例患者经新辅助化疗后,达到PCR的有30例(34.5%)。年轻乳腺癌新辅助化疗后PCR检测比例与雌激素受体(ER)、孕激素受体(PR)、术前淋巴结状态、Ki67水平及分子分型相关(χ2值分别为3.592、4.614、8.373、4.251、14.569,P值分别为0.047、0.032、0.039、0.039、0.006;Er、PR及人表皮生长因子受体2 2、HER-2复发转移患者比例与肿瘤大小、淋巴结状况相关(χ2值分别为8.778、6.243、9.413、14.910、23.074,P值分别为0.003、0.013、0.009、0.002,< 0.001);死亡患者比例与Er、PR、HER-2、肿瘤分级、肿瘤大小、淋巴结状况相关(χ2值分别为6.686、4.340、11.874、15.707、12.428、26.564,P值分别为0.010、0.037、0.003、< 0.001、0.006、< 0.001)。Er、PR、HER-2、肿瘤大小、术前淋巴结状态、分子分型与DFS相关(HR(95%CI)分别为0.53(0.31-0.93)、2.12(1.21-3.64)、0.46(0.27-0.77)、1.91(1.40-2.62)、2.22(1.55-3.20)、1.21 (0.95-1.55),P均< 0.05),Er、PR、HER-2、分类、肿瘤大小、术前淋巴结状态与OS密切相关(HR(95%CI)分别为0.47(0.23-0.98)、2.14(1.03-4.44)、0.37(0.19-0.76)、2.90(1.45-5.79)、1.86(1.24-2.79)、2.22 (1.39-3.56);(均P < 0.05)。33例复发转移患者中有5例(16.7%)达到PCR,其余28例(49.1%)未达到PCR,占所有非PCR患者的49.1%(28/57)。两组间差异有统计学意义(P = 0.019)。21例死亡患者中,PCR患者2例,占全部PCR患者的6.7% (2/30);其余19例未达到PCR,占全部未达到PCR患者的33.3%(19/57)。两组间差异有统计学意义(P= 0.026)。结论年轻乳腺癌患者新辅助化疗后的PCR、DFS和OS比例受多种临床病理因素的影响。关键词:青年乳腺癌;新辅助化疗;病理完全缓解率;无病生存;总生存期
{"title":"Analysis of the factors influencing the pathological complete remission and prognosis of young breast cancer patients after neoadjuvant chemotherapy","authors":"Weina Chen, Yantao Wang, W. Di, B. Kong","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.002","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.002","url":null,"abstract":"Objective \u0000To explore the clinicopathological factors that influence the prognosis and pathological complete response (PCR) of young breast cancer patients after neoadjuvant chemotherapy. \u0000 \u0000 \u0000Methods \u0000From January 2007 to December 2017, 87 cases of female breast cancer patients aged ≤40 who received neoadjuvant chemotherapy and were admitted to the breast surgery department of Qingdao 8th people′s hospital were analyzed retrospectively.According to the pathological results, , the patients were divided into three groups: 30 in the PCR group and 57 in the non PCR group. To compare the correlation between the composition of PCR, recurrence/metastasis and death and clinicopathological characteristics, and to analyze the relationship between PCR and disease-free survival(DFS) and overall survival(OS). \u0000 \u0000 \u0000Results \u0000After neoadjuvant chemotherapy, 30 of the 87 patients reached to PCR (34.5%). The proportion of PCR after neoadjuvant chemotherapy in young breast cancer is related to estrogen receptor (ER), progesterone receptor (PR), preoperative lymph node status, Ki67 level and molecular typing( χ2 values were 3.592, 4.614, 8.373, 4.251 and 14.569, respectively, P values were 0.047, 0.032, 0.039, 0.039 and 0.006, respectively; the proportion of recurrence and metastasis patients with Er, PR and human epidermal growth factor receptor 2 2, HER-2, tumor size and lymph node status were correlated (χ2 values were 8.778, 6.243, 9.413, 14.910, 23.074, P values were 0.003, 0.013, 0.009, 0.002, < 0.001, respectively); the proportion of dead patients was correlated with Er, PR, HER-2, grade, tumor size and lymph node status (χ2 values were 6.686, 4.340, 11.874, 15.707, 12.428, 26.564, respectively, P values were 0.010, 0.037, 0.003, < 0.001, 0.006, < 0.001). Er, PR, HER-2, tumor size, preoperative lymph node status and molecular typing were correlated with DFS (HR(95%CI) was 0.53 (0.31-0.93), 2.12 (1.21-3.64), 0.46 (0.27-0.77), 1.91 (1.40-2.62), 2.22 (1.55-3.20), 1.21 (0.95-1.55), all P< 0.05), while er, PR, HER-2, classification, tumor size and preoperative lymph node status were closely correlated with OS (HR(95%CI was 0.47 (0.23-0.98), 2.14 (1.03-4.44), 0.37 (0.19-0.76), 2.90 (1.45-5.79), 1.86 (1.24-2.79) and 2.22 (1.39-3.56), respectively (all P < 0.05)). Among the 33 patients with recurrence and metastasis, 5 (16.7%)patients had PCR, while the remaining 28 (49.1%)patients had not reached PCR, accounting for 49.1% (28/57) of all the non PCR patients. The difference between the two groups was statistically significant (P = 0.019). Among the 21 patients who died, there were 2 patients with PCR, accounting for 6.7% (2/30) of all the patients with PCR; the remaining 19 patients did not reach PCR, accounting for 33.3% (19/57) of all the patients without PCR. The difference between the two groups was statistically significant(P= 0.026). \u0000 \u0000 \u0000Conclusion \u0000The proportion of PCR, DFS and OS in young breast cancer patients after neoadjuvant chemotherapy were affected ","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48656345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of CD4+ CD25+ FoxP3+ Treg cells in patients with myelodysplastic syndrome and the effect of cyclosporine 骨髓增生异常综合征患者CD4+ CD25+ FoxP3+ Treg细胞的特征及环孢素的影响
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.014
Zeng-sheng Wang, Yan Li, Tao Lang, Xiao-yan Zhang, L. Fu, H. Ai, Xiaoming Wang
Objective To investigate the expression levels of CD4+ CD25+ FOXP3+ Treg cells and interleukin(IL)-10 in serum of patients with myelodysplastic syndrome (MDS) - refractory anemia (RA) and refractory hematopenia with multilineage dysplasia (RCMD), and to evaluate the effect of cyclosporine on CD4+ CD25+ FOXP3+ Treg cells in MDS patients. Methods From January 2016 to January 2018, 25 MDS-RA and RCMD patients and 13 healthy controls were selected from people′s Hospital of Xinjiang Uygur Autonomous Region for retrospective analysis.The expression of CD4 + CD25 + Foxp3 + Treg and IL-10 in peripheral blood samples were detected by flow cytometry and enzyme-linked immunosorbent assay.The expression of CD4 + CD25 + Foxp3 + Treg and IL-10 in MDS-RA and RCMD patients before and 6 months after the treatment with CSA based immunosuppressive regimen was detected. Results Of the 25 patients, 13 (52%) were effective and 12 (48%) were ineffective.The proportion of CD4 + CD25 + Foxp3 + Treg in CD4 + T cells of MDS group was significantly higher than that of healthy control group [(0.37 ± 0.10)% and (0.12 ± 0.06)% respectively, t= 2.02, P< 0.001]. The level of IL 10 in MDS group was significantly higher than that in healthy control group ((7.16±1.27) μg /L and (2.75 ± 1.06) μg /L, t= 2.03, P< 0.001). The ratio of CD4 + CD25 + Foxp3 + Treg cells in MDS group was lower than that in MDS Group ((0.15±0.06)% and (0.26±0.08%), t= 1.71, P< 0.001), and the level of IL 10 in MDS group was lower than that in MDS Group ((3.22±1.01) μg /L and (4.25±1.22) μg /L, t= 2.06, P= 0.030). The proportion of CD4 + CD25 + Foxp3 + Treg in peripheral blood of 25 MDS patients was positively correlated with the level of IL-10 expression (r= 0.35, P= 0.02). Conclusion The expression of CD4+ CD25+ FOXP3+ Treg cells and IL-10 increased in MDS patients increased, but decreased after cyclosporine treatment. Key words: Myelodysplastic syndrome; CD4+ CD25+ FOXP3+ Treg cells; Interleukin 10
目的研究骨髓增生异常综合征(MDS)-难治性贫血(RA)和难治性血细胞减少伴多谱系发育不良(RCMD)患者血清中CD4+CD25+FOXP3+Treg细胞和白细胞介素(IL)-10的表达水平,评价环孢菌素对MDS患者CD4+CD25+FOXP3+Treg细胞的影响。方法选择2016年1月至2018年1月新疆维吾尔自治区人民医院收治的25例MDS-RA和RCMD患者和13名健康对照进行回顾性分析。流式细胞仪和酶联免疫吸附法检测外周血CD4+CD25+Foxp3+Treg和IL-10的表达。检测基于CSA的免疫抑制方案治疗前和治疗后6个月MDS-RA和RCMD患者CD4+CD25+Foxp3+Treg和IL-10的表达。结果25例患者中,有效13例(52%),无效12例(48%)。MDS组CD4+T细胞中CD4+CD25+Foxp3+Treg的比例显著高于健康对照组[分别为(0.37±0.10)%和(0.12±0.06)%,T=2.02,P<0.001],CD4+CD25+Foxp3+Treg细胞比例MDS组低于MDS组((0.15±0.06)%和(0.26±0.08%),t=1.71,P<0.001),IL-10水平MDS组低于(3.22±1.01)μg/L和(4.25±1.22)μg/L,t=2.06,CD4+CD25+Foxp3+Treg在25例MDS患者外周血中的比例与IL-10的表达呈正相关(r=0.35,P=0.02)。关键词:骨髓增生异常综合征;CD4+CD25+FOXP3+Treg细胞;白细胞介素10
{"title":"Characteristics of CD4+ CD25+ FoxP3+ Treg cells in patients with myelodysplastic syndrome and the effect of cyclosporine","authors":"Zeng-sheng Wang, Yan Li, Tao Lang, Xiao-yan Zhang, L. Fu, H. Ai, Xiaoming Wang","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.014","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.014","url":null,"abstract":"Objective \u0000To investigate the expression levels of CD4+ CD25+ FOXP3+ Treg cells and interleukin(IL)-10 in serum of patients with myelodysplastic syndrome (MDS) - refractory anemia (RA) and refractory hematopenia with multilineage dysplasia (RCMD), and to evaluate the effect of cyclosporine on CD4+ CD25+ FOXP3+ Treg cells in MDS patients. \u0000 \u0000 \u0000Methods \u0000From January 2016 to January 2018, 25 MDS-RA and RCMD patients and 13 healthy controls were selected from people′s Hospital of Xinjiang Uygur Autonomous Region for retrospective analysis.The expression of CD4 + CD25 + Foxp3 + Treg and IL-10 in peripheral blood samples were detected by flow cytometry and enzyme-linked immunosorbent assay.The expression of CD4 + CD25 + Foxp3 + Treg and IL-10 in MDS-RA and RCMD patients before and 6 months after the treatment with CSA based immunosuppressive regimen was detected. \u0000 \u0000 \u0000Results \u0000Of the 25 patients, 13 (52%) were effective and 12 (48%) were ineffective.The proportion of CD4 + CD25 + Foxp3 + Treg in CD4 + T cells of MDS group was significantly higher than that of healthy control group [(0.37 ± 0.10)% and (0.12 ± 0.06)% respectively, t= 2.02, P< 0.001]. The level of IL 10 in MDS group was significantly higher than that in healthy control group ((7.16±1.27) μg /L and (2.75 ± 1.06) μg /L, t= 2.03, P< 0.001). The ratio of CD4 + CD25 + Foxp3 + Treg cells in MDS group was lower than that in MDS Group ((0.15±0.06)% and (0.26±0.08%), t= 1.71, P< 0.001), and the level of IL 10 in MDS group was lower than that in MDS Group ((3.22±1.01) μg /L and (4.25±1.22) μg /L, t= 2.06, P= 0.030). The proportion of CD4 + CD25 + Foxp3 + Treg in peripheral blood of 25 MDS patients was positively correlated with the level of IL-10 expression (r= 0.35, P= 0.02). \u0000 \u0000 \u0000Conclusion \u0000The expression of CD4+ CD25+ FOXP3+ Treg cells and IL-10 increased in MDS patients increased, but decreased after cyclosporine treatment. \u0000 \u0000 \u0000Key words: \u0000Myelodysplastic syndrome; CD4+ CD25+ FOXP3+ Treg cells; Interleukin 10","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49020516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic value of alpha fetoprotein, leucine aminopeptidase and α L fucosidase in primary liver cancer 甲胎蛋白、亮氨酸氨基肽酶和α L聚焦酶在原发性肝癌中的诊断价值
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.003
Zhi-ping Guo
Objective To investigate the detection of neutrophil gelatinase related lipid carrier protein (NGAL), alpha fetoprotein (AFP), leucine aminopeptidase (LAP), alpha L fucosidase (AFU) in primary liver cancer (PHC) individually and jointly The diagnostic value of cancer (PHC). Methods From January 2015 to December 2017, 124 patients with primary liver cancer from the third people′s Hospital of Yunnan Province were selected as PHC group, 53 patients with cirrhosis treated at the same time as benign group A, 37 patients with liver cyst as benign group B, and 64 healthy volunteers as healthy group. The serum AFU, LAP, NGAL and AFP of four groups of subjects were detected by rate method, immunoturbidimetric method and electrochemiluminescence method respectively. The diagnostic efficacy of PHC detected by different combinations of indicators was analyzed by receiver operating characteristic curve (ROC). Results There were significant differences in serum AFP, AFU, LAP levels and positive expression rates between PHC group, benign group A, group B and healthy group(F values were 56.832, 38.209, 23.415, respectively; χ2 values were 69.324, 72.568, 24.695, respectively; all P<0.05), and the serum AFP, AFU, LAP levels and positive expression rate were significantly higher in the PHC group than in the benign group A, group B and healthy group, the difference was statistically significant( all P<0.05); sensitivity of AFP+ AFU+ LAP combined detection(89.27% vs.72.17%, 73.52%, 76.31%, 81.35%, 80.69%, 86.87%), specificity(95.76% vs.81.58%, 82.79%, 84.16%, 86.95%, 94.23%, 93.29%) and the Yoden index (0.85 and 0.54, 0.56, 0.60, 0.68, 0.75, 0.80) are superior to their one indicator (LAP, AFU, AFP) and two indexes combined detection(LAP+ AFU, LAP+ AFP, AFU+ AFP). ROC curve analysis showed that the AUC(0.94) combined with AFP+ AFU+ LAP was greater than LAP+ AFU(0.78), LAP+ AFP(0.85) and AFU+ AFP(0.89). Conclusion Combined detection of AFP, AFU and LAP can effectively improve the diagnosis efficiency of PHC and reduce missed diagnosis. Key words: Primary hepatic cancer; Lipid carrier protein; Alpha fetoprotein; Leucine aminopeptidase; α-L-Fucosidase; Diagnosis
目的探讨中性粒细胞明胶酶相关脂质载体蛋白(NGAL)、甲胎蛋白(AFP)、亮氨酸氨基肽酶(LAP)、α-L-岩藻糖苷酶(AFU)在原发性癌症(PHC)中的单独检测和联合检测,探讨其对癌症的诊断价值。方法选择云南省第三人民医院2015年1月至2017年12月收治的原发性肝癌患者124例为PHC组,同期治疗的肝硬化患者53例为良性A组,肝囊肿患者37例为良性B组,健康志愿者64例为健康组。分别用速率法、免疫比浊法和电化学发光法检测四组受试者血清AFU、LAP、NGAL和AFP。采用受试者工作特性曲线(ROC)分析不同指标组合对PHC的诊断效果。结果PHC组、良性A组、B组和健康组血清AFP、AFU、LAP水平及阳性表达率差异有统计学意义(F值分别为56.832、38.209、23.415;χ2值分别为69.324、72.568、24.695;均P<0.05),PHC组LAP水平和阳性表达率均显著高于良性A组、B组和健康组,差异有统计学意义(均P<0.05);AFP+AFU+LAP联合检测的敏感性(89.27%对72.17%、73.52%、76.31%、81.35%、80.69%、86.87%)、特异性(95.76%对81.58%、82.79%、84.16%、86.95%、94.23%、93.29%)和约登指数(0.85和0.54、0.56、0.60、0.68、0.75、0.80)优于其一项指标(LAP、AFU、AFP)和两项指标联合检测(LAP+AFU、LAP+AFP、AFU+AFP)。ROC曲线分析显示,AFP+AFU+LAP联合检测的AUC(0.94)大于LAP+AFU(0.78)、LAP+AFP(0.85)和AFU+AFP(0.89)。关键词:原发性癌症;脂质载体蛋白;甲胎蛋白;亮氨酸氨肽酶;α-L-岩藻糖苷酶;诊断
{"title":"Diagnostic value of alpha fetoprotein, leucine aminopeptidase and α L fucosidase in primary liver cancer","authors":"Zhi-ping Guo","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.003","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.003","url":null,"abstract":"Objective \u0000To investigate the detection of neutrophil gelatinase related lipid carrier protein (NGAL), alpha fetoprotein (AFP), leucine aminopeptidase (LAP), alpha L fucosidase (AFU) in primary liver cancer (PHC) individually and jointly The diagnostic value of cancer (PHC). \u0000 \u0000 \u0000Methods \u0000From January 2015 to December 2017, 124 patients with primary liver cancer from the third people′s Hospital of Yunnan Province were selected as PHC group, 53 patients with cirrhosis treated at the same time as benign group A, 37 patients with liver cyst as benign group B, and 64 healthy volunteers as healthy group. The serum AFU, LAP, NGAL and AFP of four groups of subjects were detected by rate method, immunoturbidimetric method and electrochemiluminescence method respectively. The diagnostic efficacy of PHC detected by different combinations of indicators was analyzed by receiver operating characteristic curve (ROC). \u0000 \u0000 \u0000Results \u0000There were significant differences in serum AFP, AFU, LAP levels and positive expression rates between PHC group, benign group A, group B and healthy group(F values were 56.832, 38.209, 23.415, respectively; χ2 values were 69.324, 72.568, 24.695, respectively; all P<0.05), and the serum AFP, AFU, LAP levels and positive expression rate were significantly higher in the PHC group than in the benign group A, group B and healthy group, the difference was statistically significant( all P<0.05); sensitivity of AFP+ AFU+ LAP combined detection(89.27% vs.72.17%, 73.52%, 76.31%, 81.35%, 80.69%, 86.87%), specificity(95.76% vs.81.58%, 82.79%, 84.16%, 86.95%, 94.23%, 93.29%) and the Yoden index (0.85 and 0.54, 0.56, 0.60, 0.68, 0.75, 0.80) are superior to their one indicator (LAP, AFU, AFP) and two indexes combined detection(LAP+ AFU, LAP+ AFP, AFU+ AFP). ROC curve analysis showed that the AUC(0.94) combined with AFP+ AFU+ LAP was greater than LAP+ AFU(0.78), LAP+ AFP(0.85) and AFU+ AFP(0.89). \u0000 \u0000 \u0000Conclusion \u0000Combined detection of AFP, AFU and LAP can effectively improve the diagnosis efficiency of PHC and reduce missed diagnosis. \u0000 \u0000 \u0000Key words: \u0000Primary hepatic cancer; Lipid carrier protein; Alpha fetoprotein; Leucine aminopeptidase; α-L-Fucosidase; Diagnosis","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48163815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical analysis of 16 cases of remedial stent placement after mechanical thrombectomy for acute cerebral infarction 急性脑梗死机械取栓后行支架置入术16例临床分析
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.008
Q. Zhu, Qi Sun
Objective To explore the efficacy and safety of the remedial stent implantation after mechanical thrombectomy for acute cerebral infarction. Methods From October 2014 to December 2018, the clinical data of 16 patients with acute cerebral infarction who could not maintain forward blood flow after mechanical thrombectomy in 985 Hospital of joint service support force of PLA were analyzed retrospectively.To analyze the score of National Institutes of Health Stroke Scale (NIHSS), degree of vascular recanalization after operation thrombolysis incerebral infarction(TICI) classificatio, mechanical thrombolytic number, postoperative vascular reocclusion rate, incidence of intracranial hemorrhage, NIHSS score 1 week later, good clinical result after 90 days(improved Rankin scale, mRs= 0-2) and other indicators. Results After mechanical embolectomy, 16 stents were implanted (15 of them were Solitaire stents, 1 of them was Apollo stents), 12 patients with TICI=3, and 4 patients with TICI=2b.The average number of times of mechanical thrombectomy was(3.25±1.09). Balloon expansion was performed before stent placement in 7 patients with limited stenosis.The time from the onset to the reperfusion was(10.96 ± 3.24) hours. Computed tomography angiography(CTA) was reexamined 24 hours after operation, showing vascular of 3 cases were reocclusion and 3 cases occured intracranial hemorrhage(all less than 10 ml). In 2 cases of decompressive osteotomy, NIHSS score was improved from preoperative (24.25±4.58) points to postoperative (7.44±5.09) points.After 90 days, 10 patients had a good prognosis (mRs ≤ 2) and 1 patient died (pulmonary infection). Conclusion After mechanical thrombectomy of acute cerebral infarction, if there is severe stenosis or forward blood flow can not be maintained, use the Solitaire stent or other stent to remedy the placement, with fewer complications and better clinical effect. Key words: Acute ischemic stroke; Stent implantation; Remedial treatment; Mechanical thrombectomy
目的探讨急性脑梗死机械取栓后支架置入术的疗效和安全性。方法回顾性分析2014年10月至2018年12月解放军联勤保障部队985医院机械取栓后不能维持前方血流的16例急性脑梗死患者的临床资料。分析美国国立卫生研究院卒中量表(NIHSS)评分、术后血管再通程度、脑梗死溶栓(TICI)分类、机械溶栓次数、术后血管再闭塞率、颅内出血发生率、1周后NIHSS评分、90天后临床效果良好(改进型Rankin量表,mRs= 0-2)等指标。结果机械栓塞切除术后植入支架16例(其中Solitaire支架15例,Apollo支架1例),TICI=3的患者12例,TICI=2b的患者4例。机械取栓次数平均为(3.25±1.09)次。7例局限性狭窄患者在置入术前行球囊扩张术。从发病到再灌注时间为(10.96±3.24)小时。术后24小时复查ct血管造影(CTA), 3例血管再闭塞,3例颅内出血,均小于10 ml。2例行减压截骨术,NIHSS评分由术前(24.25±4.58)分提高至术后(7.44±5.09)分。90 d后,10例预后良好(mRs≤2),1例死亡(肺部感染)。结论急性脑梗死机械取栓后,若存在严重狭窄或不能维持前向血流,可采用接龙支架或其他支架补置,并发症少,临床效果好。关键词:急性缺血性脑卒中;支架植入术;补救治疗;机械血栓切除术
{"title":"Clinical analysis of 16 cases of remedial stent placement after mechanical thrombectomy for acute cerebral infarction","authors":"Q. Zhu, Qi Sun","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.008","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.008","url":null,"abstract":"Objective To explore the efficacy and safety of the remedial stent implantation after mechanical thrombectomy for acute cerebral infarction. Methods From October 2014 to December 2018, the clinical data of 16 patients with acute cerebral infarction who could not maintain forward blood flow after mechanical thrombectomy in 985 Hospital of joint service support force of PLA were analyzed retrospectively.To analyze the score of National Institutes of Health Stroke Scale (NIHSS), degree of vascular recanalization after operation thrombolysis incerebral infarction(TICI) classificatio, mechanical thrombolytic number, postoperative vascular reocclusion rate, incidence of intracranial hemorrhage, NIHSS score 1 week later, good clinical result after 90 days(improved Rankin scale, mRs= 0-2) and other indicators. Results After mechanical embolectomy, 16 stents were implanted (15 of them were Solitaire stents, 1 of them was Apollo stents), 12 patients with TICI=3, and 4 patients with TICI=2b.The average number of times of mechanical thrombectomy was(3.25±1.09). Balloon expansion was performed before stent placement in 7 patients with limited stenosis.The time from the onset to the reperfusion was(10.96 ± 3.24) hours. Computed tomography angiography(CTA) was reexamined 24 hours after operation, showing vascular of 3 cases were reocclusion and 3 cases occured intracranial hemorrhage(all less than 10 ml). In 2 cases of decompressive osteotomy, NIHSS score was improved from preoperative (24.25±4.58) points to postoperative (7.44±5.09) points.After 90 days, 10 patients had a good prognosis (mRs ≤ 2) and 1 patient died (pulmonary infection). Conclusion After mechanical thrombectomy of acute cerebral infarction, if there is severe stenosis or forward blood flow can not be maintained, use the Solitaire stent or other stent to remedy the placement, with fewer complications and better clinical effect. Key words: Acute ischemic stroke; Stent implantation; Remedial treatment; Mechanical thrombectomy","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43314433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the mechanism of atrioventricular reentrant tachycardia with RR interval alternation 房室折返性心动过速伴RR间期交替的发病机制研究
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.010
Wenhua Lin, C. Di, P. Gao, Qun Wang
Objective To explore the mechanism of the alternation of RR interval length in atrioventricular reentrant tachycardia (AVRT). Methods From August 2009 to August 2016, 317 patients with AVRT were treated by radiofrequency catheter ablation in cardiology department of TEDA International Cardiovascular Hospital were analyzed retrospectively.During AVRT, 5 mg of verapamil was given slowly intravenously for 10 min.After administration, the changes of RR interval, AH interval, HV interval and VA interval were observed and the time of changes was also observed. Results After administration of verapamil, there were 8 patients with RR interval alternation and QRS wave alternation.When RR interval alternation occurred, the difference of AH interval between adjacent heart beats was gradually extended, without AH jump, and the HV interval and VA interval were constant.This phenomenon occurred 6-17 minutes after administration, and the average cycle of tachycardia was 16-42 ms longer than before administration.In 3 patients, RR interval alternation occurred.When the phenomenon disappeared, the difference of AH interval between adjacent heart beats was gradually shortened, there was no AH jump, and the interval between HV and VA was constant until AH interval was equal, the disappearance time was 19-57 min after administration; AVRT was terminated in 5 patients after administration. Conclusion It can be concluded that the mechanism is due to the frequency dependent decreasing conduction of AH interval in tachycardia, which can not be induced by program stimulation. Key words: Verapamil; Atrioventricular reciprocating tachycardia; Electrophysiology; Catheter ablation; RR interval alternative
目的探讨房室折返性心动过速(AVRT) RR间期长短变化的机制。方法回顾性分析2009年8月至2016年8月泰达国际心血管医院心内科射频导管消融治疗AVRT患者317例。AVRT期间,维拉帕米5 mg缓慢静脉滴注10 min,给药后观察RR间期、AH间期、HV间期、VA间期的变化及变化时间。结果维拉帕米治疗后,8例患者出现RR间期交替和QRS波交替。当发生RR间期交替时,相邻心跳间期AH差逐渐扩大,无AH跳变,HV间期和VA间期保持不变。该现象发生于给药后6 ~ 17 min,平均心动过速周期较给药前延长16 ~ 42 ms。3例患者出现RR间期交替。当该现象消失后,相邻心跳间期AH差逐渐缩短,AH无跳跃,HV与VA间期保持不变,直至AH间期相等,给药后消失时间为19 ~ 57 min;5例患者给药后AVRT终止。结论其机制可能与心动过速AH间期传导频率依赖性降低有关,而非程序性刺激所致。关键词:维拉帕米;房室往复式心动过速;电生理学;导管消融;RR区间选择
{"title":"Study on the mechanism of atrioventricular reentrant tachycardia with RR interval alternation","authors":"Wenhua Lin, C. Di, P. Gao, Qun Wang","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.010","url":null,"abstract":"Objective \u0000To explore the mechanism of the alternation of RR interval length in atrioventricular reentrant tachycardia (AVRT). \u0000 \u0000 \u0000Methods \u0000From August 2009 to August 2016, 317 patients with AVRT were treated by radiofrequency catheter ablation in cardiology department of TEDA International Cardiovascular Hospital were analyzed retrospectively.During AVRT, 5 mg of verapamil was given slowly intravenously for 10 min.After administration, the changes of RR interval, AH interval, HV interval and VA interval were observed and the time of changes was also observed. \u0000 \u0000 \u0000Results \u0000After administration of verapamil, there were 8 patients with RR interval alternation and QRS wave alternation.When RR interval alternation occurred, the difference of AH interval between adjacent heart beats was gradually extended, without AH jump, and the HV interval and VA interval were constant.This phenomenon occurred 6-17 minutes after administration, and the average cycle of tachycardia was 16-42 ms longer than before administration.In 3 patients, RR interval alternation occurred.When the phenomenon disappeared, the difference of AH interval between adjacent heart beats was gradually shortened, there was no AH jump, and the interval between HV and VA was constant until AH interval was equal, the disappearance time was 19-57 min after administration; AVRT was terminated in 5 patients after administration. \u0000 \u0000 \u0000Conclusion \u0000It can be concluded that the mechanism is due to the frequency dependent decreasing conduction of AH interval in tachycardia, which can not be induced by program stimulation. \u0000 \u0000 \u0000Key words: \u0000Verapamil; Atrioventricular reciprocating tachycardia; Electrophysiology; Catheter ablation; RR interval alternative","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45251640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical advantage of nano carbon suspension mapping in the number of axillary lymph nodes detected after neoadjuvant chemotherapy for breast cancer 纳米碳悬液标测乳腺癌新辅助化疗后腋窝淋巴结数的临床优势
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.005
Exian Mu, Purong Zhang, Jianhui Zhang, Shiwei Liu, Li Xia
Objective To compare the advantages of nano carbon suspension mapping method and non dye method in the number of axillary lymph nodes detected during axillary lymph node dissection and axillary micro lymph nodes detected after neoadjuvant chemotherapy for breast cancer. Methods From January 1st, 2018 to July 1st, 2018, 66 breast cancer patients who were to undergo axillary lymph node dissection after new adjuvant treatment were selected for the prospective study.Using the method of random number table, the patients were randomly divided into two groups: the group of nano carbon mapping (33 cases) and the control group (33 cases). After 24 hours subcutaneous injection of nano carbon before operation, axillary lymph node dissection and direct axillary lymph node dissection without dye were used.The number of axillary lymph nodes and the number of micro axillary lymph nodes in the two groups were observed. Results The number of axillary lymph nodes and micro lymph nodes in the nano carbon mapping group were higher than those in the control group.The differences were statistically significant (the number of axillary lymph nodes were (19.3±6.2) vs (14.9±6.7), P=0.007; the number of micro-lymph nodes were 2.0(0.5, 3.0) vs 0(0, 1.0), Z=-4.328, P<0.001). Conclusion Nano carbon suspension mapping can increase the number of lymph nodes detected in axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer, and also has advantages in the detection of some small axillary lymph nodes that are not easy to find. Key words: Breast cancer; Carbon nanoparticle suspension; Axillary lymph node dissection; Micro-lymph nodes; Neoadjuvant chemotherapy
目的比较纳米碳悬液标测法和非染色法在癌症腋窝淋巴结清扫和新辅助化疗后腋窝微淋巴结检测中的优势。方法选择自2018年1月1日至2018年7月1日接受新辅助治疗的66例癌症患者进行腋窝淋巴结清扫的前瞻性研究。采用随机数表法,将患者随机分为两组:纳米碳标测组(33例)和对照组(33例行)。术前皮下注射纳米碳24小时后,采用腋窝淋巴结清扫和无染料直接腋窝淋巴结清除。观察两组患者的腋窝淋巴结数目和微腋窝淋巴结数。结果纳米碳标测组腋窝淋巴结和微淋巴结数均高于对照组。差异有统计学意义(腋窝淋巴结数分别为(19.3±6.2)和(14.9±6.7),P=0.007;微淋巴结数为2.0(0.5,3.0)vs 0(0,1.0),Z=-4.328,P<0.001)。关键词:乳腺癌症;碳纳米粒子悬浮液;腋窝淋巴结清扫;微淋巴结;新辅助化疗
{"title":"The clinical advantage of nano carbon suspension mapping in the number of axillary lymph nodes detected after neoadjuvant chemotherapy for breast cancer","authors":"Exian Mu, Purong Zhang, Jianhui Zhang, Shiwei Liu, Li Xia","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.005","url":null,"abstract":"Objective \u0000To compare the advantages of nano carbon suspension mapping method and non dye method in the number of axillary lymph nodes detected during axillary lymph node dissection and axillary micro lymph nodes detected after neoadjuvant chemotherapy for breast cancer. \u0000 \u0000 \u0000Methods \u0000From January 1st, 2018 to July 1st, 2018, 66 breast cancer patients who were to undergo axillary lymph node dissection after new adjuvant treatment were selected for the prospective study.Using the method of random number table, the patients were randomly divided into two groups: the group of nano carbon mapping (33 cases) and the control group (33 cases). After 24 hours subcutaneous injection of nano carbon before operation, axillary lymph node dissection and direct axillary lymph node dissection without dye were used.The number of axillary lymph nodes and the number of micro axillary lymph nodes in the two groups were observed. \u0000 \u0000 \u0000Results \u0000The number of axillary lymph nodes and micro lymph nodes in the nano carbon mapping group were higher than those in the control group.The differences were statistically significant (the number of axillary lymph nodes were (19.3±6.2) vs (14.9±6.7), P=0.007; the number of micro-lymph nodes were 2.0(0.5, 3.0) vs 0(0, 1.0), Z=-4.328, P<0.001). \u0000 \u0000 \u0000Conclusion \u0000Nano carbon suspension mapping can increase the number of lymph nodes detected in axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer, and also has advantages in the detection of some small axillary lymph nodes that are not easy to find. \u0000 \u0000 \u0000Key words: \u0000Breast cancer; Carbon nanoparticle suspension; Axillary lymph node dissection; Micro-lymph nodes; Neoadjuvant chemotherapy","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42153387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of intravascular ultrasound in diagnosis and treatment of left main artery disease 血管内超声在左大动脉疾病诊断和治疗中的研究进展
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.019
Zhanxiu Zhang
Coronary angiography is the core technology in the diagnosis and treatment of coronary heart disease. The left main coronary artery (LMCA), which supplies most of the left ventricular myocardium, is the key segment of the coronary network, but because of its special anatomical characteristics, it limits the value of coronary angiography in the diagnosis. Intravascular ultrasound, as an invasive tomographic technique, has been widely used in clinic to assist coronary angiography, and its value in diagnosis and treatment of left main artery disease has been recognized by most studies. Key words: Left main artery; Intravascular ultrasound; Percutaneous coronary intervention
冠状动脉造影是诊断和治疗冠心病的核心技术。供应大部分左心室心肌的左主干冠状动脉(LMCA)是冠状动脉网络的关键部分,但由于其特殊的解剖特征,限制了冠状动脉造影在诊断中的价值。血管内超声作为一种有创断层成像技术,在临床上广泛应用于辅助冠状动脉造影,其在左主干疾病诊断和治疗中的价值已得到大多数研究的认可。关键词:左大动脉;血管内超声;经皮冠状动脉介入治疗
{"title":"Research progress of intravascular ultrasound in diagnosis and treatment of left main artery disease","authors":"Zhanxiu Zhang","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.019","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.019","url":null,"abstract":"Coronary angiography is the core technology in the diagnosis and treatment of coronary heart disease. The left main coronary artery (LMCA), which supplies most of the left ventricular myocardium, is the key segment of the coronary network, but because of its special anatomical characteristics, it limits the value of coronary angiography in the diagnosis. Intravascular ultrasound, as an invasive tomographic technique, has been widely used in clinic to assist coronary angiography, and its value in diagnosis and treatment of left main artery disease has been recognized by most studies. \u0000 \u0000 \u0000Key words: \u0000Left main artery; Intravascular ultrasound; Percutaneous coronary intervention","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49371046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of 3D printing technique in percutaneous nephrolithotomy of patients with complicated kidney stones 3D打印技术在复杂肾结石经皮肾镜取石术中的应用
Pub Date : 2020-03-01 DOI: 10.3760/CMA.J.ISSN.1008-6315.2020.02.009
Guobin Zhao, Xin Liu, Yu-hong Tang, H. Su, Lidong Tang, C. Feng, Chaoyang Li, Yu Wang, Haibin Ling
Objective To investigate the application of 3D printing technique in percutaneous nephrolithotomy (PCNL) of patients with complicated kidney stones. Methods From January 2015 to December 2017, 60 patients with complicated kidney stones were enrolled in the First Affiliated Hospital of Hebei North University for prospective study, and PCNL was proposed.All the patients were randomly divided into 3D print group (30 cases) and conventional image inspection group (30 cases, control group). Before operation, CT urography (CTU) was used in both groups.In 3D printing group, digital imaging and communications in medicine (DICOM) files of CT were extracted for 3D image postprocessing, and thermoplastic materials were used to print 3D model.In the 3D printing group, the digital imaging and communications in medicine (DICOM) files of CT were extracted for 3D image post-processing, and the 3D model was printed with thermoplastic materials.According to the comprehensive planning of 3D kidney model, a virtual safe and reliable percutaneous renal access was established for each patient, and PCNL was executed.The patients in the two groups were compared before, during and after operation.Preoperative: age, sex, body mass index, blood creatinine, stone size and CT value.During the operation: (1) the target renal calices location time; (2) the conformity between the preoperative planning and the actual operation; (3) the operation completion time.After operation: (1) stone removal rate; (2) hemoglobin reduction level; (3) postoperative recovery. Results All the 60 patients successfully completed the operation, 30 patients successfully printed out the 3D model, which can accurately express the relationship between the stone and the adjacent anatomical structure, the internal renal artery and the collecting system.Positioning time of 3D printing group in target renal calices((2.9 ± 1.5) min vs.(5.8 ± 1.7) min, P=0.023), coincidence between simulated and actual puncture calices((89.5 ± 3.5)% vs.(60.2 ± 5.7)%, P=0.005), postoperative stone removal rate ((89.9 ± 4.5)% vs.(75.9 ± 5.2)%, P=0.009), and hemoglobin levels((1.4 ± 0.5) g/L vs.(2.9 ± 1.4) g/L, P=0.032) were superior to the control group, and the difference was statistically significant.But there was no significant difference between the two groups (all P>0.05). Conclusion The 3D printed kidney model truly restores the anatomical details around the kidneys and stones, providing a stereoscopic and intuitive way to perform surgery, so it maybe has a significance guidance for percutaneous nephrolithotomy. Key words: Kidney stones; Percutaneous nephrolithotomy; Kidney model; Surgery simulation
目的探讨三维打印技术在复杂性肾结石经皮肾取石术(PCNL)中的应用。方法2015年1月至2017年12月,在河北北方大学第一附属医院对60例复杂性肾结石患者进行前瞻性研究,并提出PCNL。将所有患者随机分为3D打印组(30例)和常规图像检查组(对照组30例)。术前两组均行CT尿路造影(CTU)检查。在3D打印组中,提取CT的数字成像和医学通信(DICOM)文件进行3D图像后处理,并使用热塑性材料打印3D模型。在3D打印组中,提取CT的数字成像和医学通信(DICOM)文件进行3D图像后处理,并用热塑性材料打印3D模型。根据三维肾脏模型的综合规划,为每位患者建立虚拟安全可靠的经皮肾穿刺入路,并执行PCNL。比较两组患者术前、术中、术后的疗效。术前:年龄、性别、体重指数、血肌酐、结石大小、CT值。术中:(1)靶肾盏定位时间;(2) 术前计划与实际操作的一致性;(3) 操作完成时间。术后:(1)结石清除率;(2) 血红蛋白降低水平;(3) 术后恢复。结果60例患者全部成功完成手术,30例患者成功打印出三维模型,能够准确表达结石与邻近解剖结构、肾内动脉和收集系统之间的关系。3D打印组在目标肾盏中的定位时间((2.9±1.5)min vs.(5.8±1.7)min,P=0.023),模拟与实际穿刺盏之间的一致性((89.5±3.5)%vs.(60.2±5.7)%,P=0.005),术后结石清除率((89.9±4.5)%vs.(75.9±5.2)%,P=0.009),血红蛋白水平((1.4±0.5)g/L vs.(2.9±1.4)g/L,P=0.032)均优于对照组,差异有统计学意义。结论3D打印的肾脏模型真实地还原了肾脏和结石周围的解剖细节,为手术提供了一种立体直观的方法,对经皮肾镜取石术有一定的指导意义。关键词:肾结石;经皮肾取石术;肾脏模型;手术模拟
{"title":"Application of 3D printing technique in percutaneous nephrolithotomy of patients with complicated kidney stones","authors":"Guobin Zhao, Xin Liu, Yu-hong Tang, H. Su, Lidong Tang, C. Feng, Chaoyang Li, Yu Wang, Haibin Ling","doi":"10.3760/CMA.J.ISSN.1008-6315.2020.02.009","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1008-6315.2020.02.009","url":null,"abstract":"Objective \u0000To investigate the application of 3D printing technique in percutaneous nephrolithotomy (PCNL) of patients with complicated kidney stones. \u0000 \u0000 \u0000Methods \u0000From January 2015 to December 2017, 60 patients with complicated kidney stones were enrolled in the First Affiliated Hospital of Hebei North University for prospective study, and PCNL was proposed.All the patients were randomly divided into 3D print group (30 cases) and conventional image inspection group (30 cases, control group). Before operation, CT urography (CTU) was used in both groups.In 3D printing group, digital imaging and communications in medicine (DICOM) files of CT were extracted for 3D image postprocessing, and thermoplastic materials were used to print 3D model.In the 3D printing group, the digital imaging and communications in medicine (DICOM) files of CT were extracted for 3D image post-processing, and the 3D model was printed with thermoplastic materials.According to the comprehensive planning of 3D kidney model, a virtual safe and reliable percutaneous renal access was established for each patient, and PCNL was executed.The patients in the two groups were compared before, during and after operation.Preoperative: age, sex, body mass index, blood creatinine, stone size and CT value.During the operation: (1) the target renal calices location time; (2) the conformity between the preoperative planning and the actual operation; (3) the operation completion time.After operation: (1) stone removal rate; (2) hemoglobin reduction level; (3) postoperative recovery. \u0000 \u0000 \u0000Results \u0000All the 60 patients successfully completed the operation, 30 patients successfully printed out the 3D model, which can accurately express the relationship between the stone and the adjacent anatomical structure, the internal renal artery and the collecting system.Positioning time of 3D printing group in target renal calices((2.9 ± 1.5) min vs.(5.8 ± 1.7) min, P=0.023), coincidence between simulated and actual puncture calices((89.5 ± 3.5)% vs.(60.2 ± 5.7)%, P=0.005), postoperative stone removal rate ((89.9 ± 4.5)% vs.(75.9 ± 5.2)%, P=0.009), and hemoglobin levels((1.4 ± 0.5) g/L vs.(2.9 ± 1.4) g/L, P=0.032) were superior to the control group, and the difference was statistically significant.But there was no significant difference between the two groups (all P>0.05). \u0000 \u0000 \u0000Conclusion \u0000The 3D printed kidney model truly restores the anatomical details around the kidneys and stones, providing a stereoscopic and intuitive way to perform surgery, so it maybe has a significance guidance for percutaneous nephrolithotomy. \u0000 \u0000 \u0000Key words: \u0000Kidney stones; Percutaneous nephrolithotomy; Kidney model; Surgery simulation","PeriodicalId":10365,"journal":{"name":"Clinical Medicine of China","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44079644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国综合临床
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1